In Vitro and in Silico Investigation of DNA Interaction, Topoisomerase I and II Inhibitory Properties of Polydatin
暂无分享,去创建一个
[1] C. Rosano,et al. From coins to cancer therapy: Gold, silver and copper complexes targeting human topoisomerases. , 2019, Bioorganic & medicinal chemistry letters.
[2] Xiyang Wang,et al. Protective effects of polydatin on multiple organ ischemia-reperfusion injury. , 2019, Bioorganic chemistry.
[3] N. Rega,et al. Shedding light on the interaction of polydatin and resveratrol with G-quadruplex and duplex DNA: a biophysical, computational and biological approach. , 2019, International journal of biological macromolecules.
[4] G. Sethi,et al. Topoisomerase inhibitors: pharmacology and emerging nanoscale delivery systems. , 2019, Pharmacological research.
[5] Ö. Çoban,et al. Novel water soluble BODIPY compounds: Synthesis, photochemical, DNA interaction, topoisomerases inhibition and photodynamic activity properties. , 2019, European journal of medicinal chemistry.
[6] Xu Song,et al. A comprehensive review of topoisomerase inhibitors as anticancer agents in the past decade. , 2019, European journal of medicinal chemistry.
[7] Burak Barut,et al. Tyrosinase and α-glucosidase inhibitory potential of compounds isolated from Quercus coccifera bark: In vitro and in silico perspectives. , 2019, Bioorganic chemistry.
[8] Changwei Qiu,et al. Targeting the ROS/PI3K/AKT/HIF‐1α/HK2 axis of breast cancer cells: Combined administration of Polydatin and 2‐Deoxy‐d‐glucose , 2019, Journal of cellular and molecular medicine.
[9] Burak Barut,et al. Investigation of the Antioxidant, α-Glucosidase Inhibitory, Anti-inflammatory, and DNA Protective Properties of Vaccinium arctostaphylos L. , 2018, Turkish journal of pharmaceutical sciences.
[10] J. Zou,et al. Polydatin suppresses proliferation and metastasis of non-small cell lung cancer cells by inhibiting NLRP3 inflammasome activation via NF-κB pathway. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[11] P. Persson,et al. Generation of hydroxyl radicals from reactions between a dimethoxyhydroquinone and iron oxide nanoparticles , 2018, Scientific Reports.
[12] D. Şöhretoğlu,et al. Recent advances in chemistry, therapeutic properties and sources of polydatin , 2018, Phytochemistry Reviews.
[13] R. Singh,et al. Therapeutic journery of nitrogen mustard as alkylating anticancer agents: Historic to future perspectives. , 2018, European journal of medicinal chemistry.
[14] W. Wilson,et al. First Structure of a Designed Minor Groove Binding Heterocyclic Cation that Specifically Recognizes Mixed DNA Base Pair Sequences. , 2017, Chemistry.
[15] M. Valko,et al. Protective role of quercetin against copper(II)-induced oxidative stress: A spectroscopic, theoretical and DNA damage study. , 2017, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[16] Haichang Wang,et al. Polydatin protects cardiomyocytes against myocardial infarction injury by activating Sirt3. , 2017, Biochimica et biophysica acta. Molecular basis of disease.
[17] C. Dardonville,et al. Functional and structural analysis of AT-specific minor groove binders that disrupt DNA–protein interactions and cause disintegration of the Trypanosoma brucei kinetoplast , 2017, Nucleic acids research.
[18] F. Azpiroz,et al. Randomised clinical trial: the analgesic properties of dietary supplementation with palmitoylethanolamide and polydatin in irritable bowel syndrome , 2017, Alimentary pharmacology & therapeutics.
[19] T. Rakshit,et al. Discriminating Intercalative Effects of Threading Intercalator Nogalamycin, from Classical Intercalator Daunomycin, Using Single Molecule Atomic Force Spectroscopy , 2016, PloS one.
[20] Ü. Demirbaş,et al. Investigation of DNA binding, DNA photocleavage, topoisomerase I inhibition and antioxidant activities of water soluble titanium(IV) phthalocyanine compounds. , 2016, Journal of photochemistry and photobiology. B, Biology.
[21] Jennifer L. Knight,et al. OPLS3: A Force Field Providing Broad Coverage of Drug-like Small Molecules and Proteins. , 2016, Journal of chemical theory and computation.
[22] H. Tajmir-Riahi,et al. Structural modeling for DNA binding to antioxidants resveratrol, genistein and curcumin. , 2015, Journal of photochemistry and photobiology. B, Biology.
[23] M. Caraglia,et al. Polydatin administration improves serum biochemical parameters and oxidative stress markers during chronic alcoholism: a pilot study. , 2015, In vivo.
[24] E. Oldfield,et al. Antibacterial drug leads: DNA and enzyme multitargeting. , 2015, Journal of medicinal chemistry.
[25] W. Denny,et al. The solution structure of bis(phenazine‐1‐carboxamide)‐DNA complexes: MLN 944 binding corrected and extended , 2014, Biopolymers.
[26] Danzhou Yang,et al. Solution structure of a 2:1 complex of anticancer drug XR5944 with TFF1 estrogen response element: insights into DNA recognition by a bis-intercalator , 2014, Nucleic acids research.
[27] H. Cai,et al. Anti-oxidant polydatin (piceid) protects against substantia nigral motor degeneration in multiple rodent models of Parkinson’s disease , 2015, Molecular Neurodegeneration.
[28] M. Caraglia,et al. Polydatin, a natural precursor of resveratrol, induces cell cycle arrest and differentiation of human colorectal Caco-2 cell , 2013, Journal of Translational Medicine.
[29] G. Margison,et al. Structures of DNA duplexes containing O6-carboxymethylguanine, a lesion associated with gastrointestinal cancer, reveal a mechanism for inducing pyrimidine transition mutations , 2013, Nucleic acids research.
[30] A. Graziottin,et al. Vestibulodynia: Synergy Between Palmitoylethanolamide + Transpolydatin and Transcutaneous Electrical Nerve Stimulation , 2013, Journal of lower genital tract disease.
[31] S. Neidle,et al. Small-molecule binding to the DNA minor groove is mediated by a conserved water cluster. , 2013, Journal of the American Chemical Society.
[32] E. Mitchell,et al. CRYSTAL STRUCTURE OF THE DB 985-D(CGCAAATTTGCG)2 COMPLEX AT 1.20 A RESOLUTION , 2013 .
[33] Zia-ur-Rehman,et al. Chemistry of DNA minor groove binding agents. , 2012, Journal of photochemistry and photobiology. B, Biology.
[34] U. Brunk,et al. Integrative and Translational Physiology : Integrative Aspects of Energy Homeostasis and Metabolic Diseases Polydatin , a natural polyphenol , protects arterial smooth muscle cells against mitochondrial dysfunction and lysosomal destabilization following hemorrhagic shock , 2012 .
[35] Lynn Farh,et al. Structural Basis of Type II Topoisomerase Inhibition by the Anticancer Drug Etoposide , 2011, Science.
[36] A. Matsuda,et al. Insights into the Structures of DNA Damaged by Hydroxyl Radical: Crystal Structures of DNA Duplexes Containing 5-Formyluracil , 2010, Journal of nucleic acids.
[37] N. Hud,et al. Crystal Structure of Proflavine in Complex with a DNA hexamer duplex , 2010 .
[38] David S. Goodsell,et al. AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility , 2009, J. Comput. Chem..
[39] Kyung-Tae Lee,et al. Molecular design, synthesis and docking study of benz[b]oxepines and 12-oxobenzo[c]phenanthridinones as topoisomerase 1 inhibitors. , 2009, Bioorganic & medicinal chemistry letters.
[40] M. Lila,et al. Catalytic inhibition of human DNA topoisomerase II by interactions of grape cell culture polyphenols. , 2006, Journal of agricultural and food chemistry.
[41] A. Canals,et al. The anticancer agent ellipticine unwinds DNA by intercalative binding in an orientation parallel to base pairs. , 2005, Acta crystallographica. Section D, Biological crystallography.
[42] F. Caruso,et al. Structural basis for antioxidant activity of trans-resveratrol: ab initio calculations and crystal and molecular structure. , 2004, Journal of agricultural and food chemistry.
[43] R. Acquaviva,et al. Bioflavonoids as antiradicals, antioxidants and DNA cleavage protectors , 2004, Cell Biology and Toxicology.
[44] M. Searle,et al. DNA recognition by the anthracycline antibiotic respinomycin D: NMR structure of the intercalation complex with d(AGACGTCT)2. , 2003, Organic & biomolecular chemistry.
[45] Lance Stewart,et al. The mechanism of topoisomerase I poisoning by a camptothecin analog , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[46] R. T. Rosen,et al. Isolation and identification of stilbenes in two varieties of Polygonum cuspidatum. , 2000, Journal of agricultural and food chemistry.
[47] T. N. Bhat,et al. The Protein Data Bank , 2000, Nucleic Acids Res..
[48] W. Denny,et al. Major groove binding and 'DNA-induced' fit in the intercalation of a derivative of the mixed topoisomerase I/II poison N-(2-(dimethylamino)ethyl)acridine-4-carboxamide (DACA) into DNA: X-ray structure complexed to d(CG(5-BrU)ACG)2 at 1.3-A resolution. , 1999, Journal of medicinal chemistry.
[49] D C Rees,et al. A structural basis for recognition of A.T and T.A base pairs in the minor groove of B-DNA. , 1998, Science.
[50] C. K. Smith,et al. DNA-drug refinement: a comparison of the programs NUCLSQ, PROLSQ, SHELXL93 and X-PLOR, using the low-temperature d(TGATCA)-nogalamycin structure. , 1996, Acta crystallographica. Section D, Biological crystallography.
[51] W. Hunter,et al. A trigonal form of the idarubicin:d(CGATCG) complex; crystal and molecular structure at 2.0 A resolution. , 1995, Nucleic acids research.
[52] R. Mehta,et al. Flavonoids as DNA topoisomerase antagonists and poisons: structure-activity relationships. , 1995, Journal of natural products.
[53] C. K. Smith,et al. DNA-nogalamycin interactions: the crystal structure of d(TGATCA) complexed with nogalamycin. , 1994, Biochemistry.
[54] G. Ughetto,et al. Interactions between morpholinyl anthracyclines and DNA. The crystal structure of a morpholino doxorubicin bound to d(CGTACG). , 1993, Journal of molecular biology.